Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37824254)
Watch
English
Role of bevacizumab therapy in the management of glioblastoma.
scientific article published on 22 April 2010
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Role of bevacizumab therapy in the management of glioblastoma
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
main subject
bevacizumab
1 reference
based on heuristic
inferred from title
author name string
Scott J Peak
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Victor A Levin
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
language of work or name
English
0 references
publication date
22 April 2010
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
published in
Cancer Management and Research
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
volume
2
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
page(s)
97-104
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
cites work
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Antiangiogenic therapies for high-grade glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Biological mechanisms of bevacizumab-associated adverse events
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Safety of anticoagulation use and bevacizumab in patients with glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Bevacizumab: a review of its use in metastatic colorectal cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
MGMT gene silencing and benefit from temozolomide in glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
An estimate of the heritable fraction of childhood cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Intravenous carboplatin for recurrent malignant glioma: a phase II study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Single-agent chemotherapy of brain tumors. A five-year review
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Chemotherapy of primary brain tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
6 September 2017
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
14 September 2017
Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
14 September 2017
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
14 September 2017
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
28 September 2017
Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
23 June 2018
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
23 June 2018
Nitrosourea chemotherapy for primary malignant gliomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
23 June 2018
Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
23 June 2018
Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Flt-1 signaling in macrophages promotes glioma growth in vivo.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Time course of imaging changes of GBM during extended bevacizumab treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Effect of bevacizumab on radiation necrosis of the brain.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Response criteria for phase II studies of supratentorial malignant glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3004572
retrieved
1 September 2018
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21188100
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Molecular biology of blood-brain barrier ontogenesis and function
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21188100
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMCID
3004572
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
PubMed ID
21188100
1 reference
stated in
Europe PubMed Central
PMCID
3004572
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21188100%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit